Research Fellow in Structural and Computational Biology

Many of the proteins that are critical for cancer development are intrinsically 
disordered or have large disordered regions. Moreover, the genetic alterations 
that promote cancer generate mutated forms of proteins that are destabilized. 
One example is the fusion protein formed from the microtubule binding protein 
EML4 and the tyrosine kinase ALK. The EML4-ALK fusion is the key driver in 
approximately 5% of non-small cell lung cancer (NSCLC) patients. Alternative 
breakpoints in the EML4 gene result in fusion proteins of different lengths and 
properties, and patients with longer forms respond better to treatment that 
those with shorter forms. We do not understand why this is the case, but we 
hypothesize that it is due to differences in protein stability and 
protein-protein interactions. The longer forms of EML4-ALK, found in two-thirds 
of patients, include only part of a tandem beta propeller (TAPE) domain. The 
broken TAPE domain does not impede the expression of the fusion protein, or 
inhibit the catalytic activity of the fused ALK kinase, and contributes 
directly to cancer signaling. This is remarkable because the folding of the 
broken TAPE domain should be severely compromised.

We are looking for a Research Fellow to explore the structural dynamics and 
interactions of disordered regions of proteins of relevance to cancer, starting 
with the broken TAPE domain of EML4-ALK. You will explore the structure and 
dynamics of the broken TAPE domain in the fusion protein, characterize its 
molecular interactions and decipher the molecular mechanisms that underpin 
cancer signaling. Approaches will include molecular simulation, biophysical 
characterization of protein folding and advanced mass spectrometry. We have a 
long-standing interest in intrinsically disordered proteins and their 
interactions, protein kinases and cancer signalling. The post is funded by a 
Programme Award from Cancer Research UK, which supports a thriving research 
group embedded in the Astbury Centre<http://www.astbury.leeds.ac.uk/> for 
Structural and Molecular Biology.

To explore the post further or for any queries you may have, please contact:

Richard 
Bayliss<http://www.astbury.leeds.ac.uk/people/staff/staffpage.php?StaffID=RWB>, 
Professor of Molecular Medicine

Tel: +44 (0)113 343 9919, email: <mailto:[email protected]> 
[email protected]<mailto:[email protected]>


Location:       Leeds - Main Campus
Faculty/Service:        Faculty of Biological Sciences
School/Institute:       School of Molecular & Cellular Biology
Category:       Research
Grade:  Grade 7
Salary:         £32,548 to £38,833 p.a.
        Due to funding limitations an appointment cannot be made above £34,520 
p.a.
Working Time:   100%
Post Type:      Full Time
Contract Type:  Fixed Term (until 28 February 2020, potential to extend for 
further 24 months - due to funding)
Closing Date:   Tuesday 02 January 2018

Reply via email to